TY  - JOUR
AU  - Davila-Gonzalez, I
AU  - Moreno-Benitez, F
AU  - Quirce, S
PY  - 2019
DO  - 10.18176/jiaci.0385
SN  - 1018-9068
UR  - http://hdl.handle.net/10668/13872
T2  - Journal of investigational allergology & clinical immunology
AB  - Eosinophilic asthma is the most common phenotype of severe asthma. It is characterized by abnormal production and release of type 2 cytokines from T helper type 2 (TH2) lymphocytes and type 2 innate lymphoid cells, such as IL-5. This leads to a...
LA  - en
PB  - Esmon
KW  - Basophils
KW  - Eosinophils
KW  - Exacerbations
KW  - ILC-2
KW  - Phenotype
KW  - Eosinofilos
KW  - Basofilos
KW  - Exacerbaciones
KW  - Fenotipo
KW  - Anti-Asthmatic Agents
KW  - Antibodies, Monoclonal, Humanized
KW  - Asthma
KW  - Basophils
KW  - Clinical Trials as Topic
KW  - Drug Therapy, Combination
KW  - Eosinophilia
KW  - Humans
KW  - Phenotype
KW  - Research
KW  - Symptom Assessment
KW  - Treatment Outcome
TI  - Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma.
TY  - research article
VL  - 29
ER  -